Skip to main content
Top
Published in: Surgical Endoscopy 4/2012

01-04-2012

Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience

Authors: Koray Karabulut, Federico Aucejo, Hizir Yakup Akyildiz, Allan Siperstein, Eren Berber

Published in: Surgical Endoscopy | Issue 4/2012

Login to get access

Abstract

Background

We have been utilizing both resection and laparoscopic radiofrequency ablation (RFA) to treat hepatocellular carcinoma (HCC). The aim of this study is to describe patient characteristics and outcome for each treatment modality from a single institution.

Methods

Medical records of HCC patients who underwent resection (n = 92) or laparoscopic (RFA) (n = 92) between 1997 and 2010 were reviewed. Univariate Kaplan–Meier and multivariate Cox proportional-hazards model were used to analyze survival.

Results

Patients with normal liver function and larger tumors were resected, and those with liver dysfunction, portal hypertension, and multiple tumors were ablated. Tumor size was larger in the Resection group, whereas number of tumors was higher in the RFA group. Child class and Barcelona Clinic Liver Cancer (BCLC) staging were more advanced in the RFA group. Hospital stay was longer, and morbidity and mortality higher in the Resection versus the RFA group. There was no difference in disease-free survival, but the 5-year actual survival was significantly higher (40% versus 21%) in the Resection group. On univariate analysis, number of tumors, tumor size, platelet count, BCLC stage, Child class, and type of surgery were predictors of overall survival. On multivariate analysis, Child class and number of tumors were independent predictors of overall survival.

Conclusions

To our knowledge, this is the largest North American series reporting on RFA and resection for HCC from a single institution. Herein, we describe the perioperative and oncologic outcomes to be expected when these modalities are used in a certain treatment algorithm.
Literature
2.
go back to reference Delis S, Bakoyiannis A, Papailiou J, Tassopoulos N, Dervenis C (2009) Liver resection vs radio-frequency ablation in the treatment of small hepatocellular carcinoma. Surg Oncol. doi:10.1016/j.suronc2009.09.001 Delis S, Bakoyiannis A, Papailiou J, Tassopoulos N, Dervenis C (2009) Liver resection vs radio-frequency ablation in the treatment of small hepatocellular carcinoma. Surg Oncol. doi:10.​1016/​j.​suronc2009.​09.​001
3.
go back to reference Ballem N, Berber E, Pitt T, Siperstein A (2008) Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up. HPB (Oxford) 10:315–320CrossRef Ballem N, Berber E, Pitt T, Siperstein A (2008) Laparoscopic radiofrequency ablation of unresectable hepatocellular carcinoma: long-term follow-up. HPB (Oxford) 10:315–320CrossRef
4.
go back to reference Liu Z, Zhou Y, Zhang P, Qin H (2010) Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma. Surg Laparosc Endosc Percutan Tech 20:130–140PubMedCrossRef Liu Z, Zhou Y, Zhang P, Qin H (2010) Meta-analysis of the therapeutic effect of hepatectomy versus radiofrequency ablation for the treatment of hepatocellular carcinoma. Surg Laparosc Endosc Percutan Tech 20:130–140PubMedCrossRef
5.
go back to reference Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N et al (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116:3638–3644PubMedCrossRef Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N et al (2010) Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 116:3638–3644PubMedCrossRef
6.
go back to reference Cassera MA, Potter KW, Ujiki MB, Swanstrom LL, Hansen PD (2010) Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs. Surg Endosc. doi: 10.1007/s00464-010-1322-5 Cassera MA, Potter KW, Ujiki MB, Swanstrom LL, Hansen PD (2010) Computed tomography (CT)-guided versus laparoscopic radiofrequency ablation: a single-institution comparison of morbidity rates and hospital costs. Surg Endosc. doi: 10.​1007/​s00464-010-1322-5
7.
go back to reference Dima SO, Iacob S, Botea F, Matei E, Dorobanfu B, Vasile S et al (2009) Multimodal treatment of hepatocellular carcinoma: an eastern European experience. Hepatogastroenterology 56:1696–1703PubMed Dima SO, Iacob S, Botea F, Matei E, Dorobanfu B, Vasile S et al (2009) Multimodal treatment of hepatocellular carcinoma: an eastern European experience. Hepatogastroenterology 56:1696–1703PubMed
8.
go back to reference Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y et al (2008) Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 55:2171–2174PubMed Hiraoka A, Horiike N, Yamashita Y, Koizumi Y, Doi K, Yamamoto Y et al (2008) Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications. Hepatogastroenterology 55:2171–2174PubMed
9.
go back to reference Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y et al (2009) Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 16:359–366PubMedCrossRef Ueno S, Sakoda M, Kubo F, Hiwatashi K, Tateno T, Baba Y et al (2009) Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 16:359–366PubMedCrossRef
10.
go back to reference Berber E, Rogers S, Siperstein A (2005) Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study. Surg Endosc 19:710–714PubMedCrossRef Berber E, Rogers S, Siperstein A (2005) Predictors of survival after laparoscopic radiofrequency thermal ablation of hepatocellular cancer: a prospective study. Surg Endosc 19:710–714PubMedCrossRef
11.
go back to reference Berber E, Herceg NL, Casto KJ, Siperstein AE (2004) Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms. Surg Endosc 18:390–396PubMedCrossRef Berber E, Herceg NL, Casto KJ, Siperstein AE (2004) Laparoscopic radiofrequency ablation of hepatic tumors: prospective clinical evaluation of ablation size comparing two treatment algorithms. Surg Endosc 18:390–396PubMedCrossRef
12.
go back to reference Tanaka S, Shimada M, Shirabe K, Taketomi A, Maehara S, Tsujita E et al (2009) Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach. Hepatogastroenterology 56:1169–1173PubMed Tanaka S, Shimada M, Shirabe K, Taketomi A, Maehara S, Tsujita E et al (2009) Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach. Hepatogastroenterology 56:1169–1173PubMed
13.
go back to reference Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N (2008) Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 12:1521–1526PubMedCrossRef Abu-Hilal M, Primrose JN, Casaril A, McPhail MJ, Pearce NW, Nicoli N (2008) Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 12:1521–1526PubMedCrossRef
14.
go back to reference Delis SG, Bakoyiannis A, Tassopoulos N, Athanassiou K, Kechagias A, Kelekis D et al (2009) Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria. HPB (Oxford) 11:551–558CrossRef Delis SG, Bakoyiannis A, Tassopoulos N, Athanassiou K, Kechagias A, Kelekis D et al (2009) Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria. HPB (Oxford) 11:551–558CrossRef
15.
go back to reference Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J et al (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the milan criteria. Ann Surg 252:903–912PubMedCrossRef Huang J, Yan L, Cheng Z, Wu H, Du L, Wang J et al (2010) A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the milan criteria. Ann Surg 252:903–912PubMedCrossRef
16.
go back to reference Tateishi R, Shiina S, Ohki T, Sato T, Masuzaki R, Imamura J et al (2009) Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol 19:142–146CrossRef Tateishi R, Shiina S, Ohki T, Sato T, Masuzaki R, Imamura J et al (2009) Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. J Gastroenterol 19:142–146CrossRef
17.
go back to reference Ng KM, Yan TD, Black D, Chu FC, Morris DL (2009) Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB (Oxford) 11:311–320CrossRef Ng KM, Yan TD, Black D, Chu FC, Morris DL (2009) Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma. HPB (Oxford) 11:311–320CrossRef
18.
go back to reference Garrean S, Hering J, Saied A, Helton WS, Espat NJ (2008) Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195:508–520PubMedCrossRef Garrean S, Hering J, Saied A, Helton WS, Espat NJ (2008) Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature. Am J Surg 195:508–520PubMedCrossRef
19.
go back to reference N’Kontchou G, Mahamoudi A, Aout M, Ganne-Carrie N, Grando V, Coderc E et al (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50:1475–1483PubMedCrossRef N’Kontchou G, Mahamoudi A, Aout M, Ganne-Carrie N, Grando V, Coderc E et al (2009) Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 50:1475–1483PubMedCrossRef
20.
go back to reference Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A et al (2010) Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 25:597–604PubMedCrossRef Waki K, Aikata H, Katamura Y, Kawaoka T, Takaki S, Hiramatsu A et al (2010) Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 25:597–604PubMedCrossRef
21.
go back to reference Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F et al (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 78:1–7 Zhou Y, Zhao Y, Li B, Xu D, Yin Z, Xie F et al (2010) Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 78:1–7
22.
go back to reference Lau WY, Lai EC (2009) The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249:20–25PubMedCrossRef Lau WY, Lai EC (2009) The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review. Ann Surg 249:20–25PubMedCrossRef
23.
go back to reference Umeda Y, Matsuda H, Sadamori H, Matsukawa H, Yagi T, Fujiwara T (2010) A prognostic model and treatment strategy for ıntrahepatic recurrence of hepatocellular carcinoma after curative resection. World J Surg 35:170–177CrossRef Umeda Y, Matsuda H, Sadamori H, Matsukawa H, Yagi T, Fujiwara T (2010) A prognostic model and treatment strategy for ıntrahepatic recurrence of hepatocellular carcinoma after curative resection. World J Surg 35:170–177CrossRef
24.
go back to reference Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F et al (2010) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study. Hepatology 53:136–147PubMedCrossRef Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F et al (2010) Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study. Hepatology 53:136–147PubMedCrossRef
25.
go back to reference Wakui N, Iida K, Ikehara T, Takayama R, Shiozawa K, Takahashi M et al (2010) Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection. Hepatogastroenterology 57:195–201PubMed Wakui N, Iida K, Ikehara T, Takayama R, Shiozawa K, Takahashi M et al (2010) Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection. Hepatogastroenterology 57:195–201PubMed
26.
go back to reference Mazzaglia PJ, Berber E, Milas M, Siperstein AE (2007) Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 142:10–19PubMedCrossRef Mazzaglia PJ, Berber E, Milas M, Siperstein AE (2007) Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 142:10–19PubMedCrossRef
27.
go back to reference Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z et al (2010) Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1, 061 cases. J Gastrointest Surg 15:311–320PubMedCrossRef Huang J, Hernandez-Alejandro R, Croome KP, Yan L, Wu H, Chen Z et al (2010) Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1, 061 cases. J Gastrointest Surg 15:311–320PubMedCrossRef
28.
go back to reference Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW et al (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as the first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–692PubMedCrossRef Choi D, Lim HK, Rhim H, Kim YS, Lee WJ, Paik SW et al (2007) Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as the first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17:684–692PubMedCrossRef
29.
go back to reference Khan MR, Poon RT, Ng KK, Chan AC, Yuen J, Tung H et al (2007) Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma. Arch Surg 142:1136–1143PubMedCrossRef Khan MR, Poon RT, Ng KK, Chan AC, Yuen J, Tung H et al (2007) Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma. Arch Surg 142:1136–1143PubMedCrossRef
30.
go back to reference Foroutani A, Garland AM, Berber E, String A, Engle K, Ryan TL et al (2000) Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg 135:933–938PubMedCrossRef Foroutani A, Garland AM, Berber E, String A, Engle K, Ryan TL et al (2000) Laparoscopic ultrasound vs triphasic computed tomography for detecting liver tumors. Arch Surg 135:933–938PubMedCrossRef
Metadata
Title
Resection and radiofrequency ablation in the treatment of hepatocellular carcinoma: a single-center experience
Authors
Koray Karabulut
Federico Aucejo
Hizir Yakup Akyildiz
Allan Siperstein
Eren Berber
Publication date
01-04-2012
Publisher
Springer-Verlag
Published in
Surgical Endoscopy / Issue 4/2012
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-011-1983-8

Other articles of this Issue 4/2012

Surgical Endoscopy 4/2012 Go to the issue